Trials / Completed
CompletedNCT05420909
A Study of Overall Survival in Participants With Metastatic Colorectal Cancer (mCRC)
Overall Survival for Metastatic Colorectal Cancer Patients Matched to CHECKMATE-142
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 124 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to estimate the overall survival (OS) for US participants diagnosed with metastatic colorectal cancer (mCRC) by using Flatiron Health's individual patient level data.
Conditions
Timeline
- Start date
- 2019-01-28
- Primary completion
- 2019-03-01
- Completion
- 2019-04-01
- First posted
- 2022-06-15
- Last updated
- 2022-08-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05420909. Inclusion in this directory is not an endorsement.